DEXAMETHASONE SODIUM PHOSPHATE | N011984 | MERCK AND CO INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Odin Pharmaceuticals, LLC FDA-2024-P-4158 Odin Pharmaceuticals LLC submitted this petition on August 30, 2024 requesting that the FDA determine whether DECADRON (Dexamethasone Sodium Phosphate) Ophthalmic Solution USP, 0.1%, approved under NDA 011984 and held by Merck and Co Inc, was withdrawn for safety or effectiveness reasons pursuant to | 505(q) | 2024-09-03 | Withdrawn | Odin Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.